Measuring dose-related efficacy of eptinezumab for migraine prevention: post hoc analysis of PROMISE-1 and PROMISE-2

Overview of attention for article published in The Journal of Headache and Pain, April 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 4,862 followers.

RT @NeuroPsychBMC: #JHeadachedPain: Measuring dose-related efficacy of #eptinezumab for #Migraine prevention https://t.co/boewFbnx16 @P_Mar…

Reply Repost Favourite

RT @NeuroPsychBMC: #JHeadachedPain: Measuring dose-related efficacy of #eptinezumab for #Migraine prevention https://t.co/boewFbnx16 @P_Mar…

Reply Repost Favourite

RT @NeuroPsychBMC: #JHeadachedPain: Measuring dose-related efficacy of #eptinezumab for #Migraine prevention https://t.co/boewFbnx16 @P_Mar…

Reply Repost Favourite

RT @NeuroPsychBMC: #JHeadachedPain: Measuring dose-related efficacy of #eptinezumab for #Migraine prevention https://t.co/boewFbnx16 @P_Mar…

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.